Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase

详细信息    查看全文

• 作者：Jin-Young Min ; MD ; PhD^a ; Christopher J. Ocampo ; MD ; PhD^b ; Whitney W. Stevens ; MD ; PhD^b ; Caroline P.E. Price ; BA^a ; Christopher F. Thompson ; MD^a ; Tetsuya Homma ; MD ; PhD^b ; ^c ; Julia H. Huang ; MS^a ; James E. Norton ; MS^b ; Lydia A. Suh ; BS^b ; Kathryn L. Pothoven ; MS^b ; David B. Conley ; MD^a ; Kevin C. Welch ; MD^a ; Stephanie Shintani-Smith ; MD ; MS^a ; Anju T. Peters ; MD^b ; Leslie C. Grammer III ; MD^b ; Kathleen E. Harris ; BS^b ; Kathryn E. Hulse ; PhD^b ; Atsushi Kato ; PhD^a ; ^b ; Nikolai N. Modyanov ; PhD^d ; Robert C. Kern ; MD^a ; ^b ; Robert P. Schleimer ; PhD^a ; ^b ; Bruce K. Tan ; MD ; MS^a ; ^{b-tan@northwestern.edu}
• 关键词：Chronic rhinosinusitis ; eotaxin-1/CCL11 ; eotaxin-2/CCL24 ; eotaxin-3/CCL26 ; omeprazole ; proton pump inhibitors ; IL-13 ; epithelial cells ; H(+)-K(+)-exchanging ATPase ; eosinophils
• 刊名：Journal of Allergy and Clinical Immunology
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：139
• 期：1
• 页码：130-141.e11
• 全文大小：2330 K
• 卷排序：139

文摘

Chronic rhinosinusitis with nasal polyps (CRSwNP) is often characterized by tissue eosinophilia that is associated with poor prognosis. Recent findings that proton pump inhibitors (PPIs) directly modulate the expression of eotaxin-3, an eosinophil chemoattractant, in patients with eosinophilic diseases suggest therapeutic potential for PPIs in those with CRSwNP.ObjectiveWe assessed the effect of type 2 mediators, particularly IL-13 and eotaxin-3, on tissue eosinophilia and disease severity in patients with chronic rhinosinusitis (CRS). Further investigation focused on PPI suppression of eotaxin-3 expression in vivo and in vitro, with exploration of underlying mechanisms.MethodsType 2 mediator levels in nasal tissues and secretions were measured by using a multiplex immunoassay. Eotaxin-3 and other chemokines expressed in IL-13–stimulated human sinonasal epithelial cells (HNECs) and BEAS-2B cells with or without PPIs were assessed by using ELISA, Western blotting, real-time PCR, and intracellular pH imaging.ResultsNasal tissues and secretions from patients with CRSwNP had increased IL-13, eotaxin-2, and eotaxin-3 levels, and these were positively correlated with tissue eosinophil cationic protein levels and radiographic scores in patients with CRS (P < .05). IL-13 stimulation of HNECs and BEAS-2B cells dominantly induced eotaxin-3 expression, which was significantly inhibited by PPIs (P < .05). Patients with CRS taking PPIs also showed lower in vivo eotaxin-3 levels compared with those without PPIs (P < .05). Using intracellular pH imaging and altering extracellular K+, we found that IL-13 enhanced H+,K+-exchange, which was blocked by PPIs and the mechanistically unrelated H,K-ATPase inhibitor, SCH-28080. Furthermore, knockdown of ATP12A (gene for the nongastric H,K-ATPase) significantly attenuated IL-13–induced eotaxin-3 expression in HNECs. PPIs also had effects on accelerating IL-13–induced eotaxin-3 mRNA decay.ConclusionOur results demonstrated that PPIs reduce IL-13–induced eotaxin-3 expression by airway epithelial cells. Furthermore, mechanistic studies suggest that the nongastric H,K-ATPase is necessary for IL-13–mediated epithelial responses, and its inhibitors, including PPIs, might be of therapeutic value in patients with CRSwNP by reducing epithelial production of eotaxin-3.